drugset / Trial / NCT07168148

Steroid Treatment for Elimination of Rebound Obstruction From Intranasal Decongestants

NCT07168148

Phase 2 Terminated 3 enrolled Washington University School of Medicine
NaSingle-groupOpen-labelTreatment

Summary

This prospective, virtually administered trial conducted throughout the United States aims to evaluate a standardized protocol including the serial dilution of topical decongestants with concurrent topical steroids (triamcinolone), for elimination of dependence on topical decongestants.

Timeline

Start
2025-11-10
Primary completion
2026-03-19
Completion
2026-03-19

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxymetazoline Other / unclassified 0 %
Subject Oxymetazoline Other / unclassified 0.0125 %
Subject Oxymetazoline Other / unclassified 0.025 %
Subject Oxymetazoline Other / unclassified 0.0375 %
Subject Oxymetazoline Other / unclassified 0.05 %
Background Triamcinolone Other / unclassified Other

Indications